↓ Skip to main content

Role of Selective Histone Deacetylase 6 Inhibitor ACY-1215 in Cancer and Other Human Diseases

Overview of attention for article published in Frontiers in Pharmacology, May 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
1 X user
patent
1 patent

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Role of Selective Histone Deacetylase 6 Inhibitor ACY-1215 in Cancer and Other Human Diseases
Published in
Frontiers in Pharmacology, May 2022
DOI 10.3389/fphar.2022.907981
Pubmed ID
Authors

Jianglei Li, Meihong Yu, Shifeng Fu, Deliang Liu, Yuyong Tan

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 18%
Other 1 9%
Unknown 8 73%
Readers by discipline Count As %
Chemistry 2 18%
Pharmacology, Toxicology and Pharmaceutical Science 1 9%
Unknown 8 73%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2023.
All research outputs
#8,044,216
of 24,865,967 outputs
Outputs from Frontiers in Pharmacology
#3,663
of 18,992 outputs
Outputs of similar age
#152,283
of 435,410 outputs
Outputs of similar age from Frontiers in Pharmacology
#168
of 1,243 outputs
Altmetric has tracked 24,865,967 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 18,992 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,410 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 1,243 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.